Introduction
Human hepatocellular carcinoma (HCC) is one of the most frequent tumors, particularly among Asian and African populations (Yamanaka et al., 1990) . A notable feature of most HCC is hypervascularity; therefore, it is likely that HCC produces angiogenic factors. Vascular endothelial growth factor (VEGF) plays an important role in the development of neovascularization in HCC, since VEGF expression is significantly higher in HCC with strong or moderate angiographic staining than in those with weak or no angiographic staining (Mise et al., 1996) . Plasminogen activator inhibitor type 1 (PAI-1) is also highly expressed in human HCC (Zhou et al., 2000) . PAI-1 is the main inhibitor of the urokinase-type plasminogen activator system, and conducts cancer cells to migration, invasion, and metastasis by blocking cellular adhesion and by promoting basement membrane degradation in a variety of malignancies (Gutierrez et al., 2000) . Another characteristic of HCC is increased production of transforming growth factor (TGF)-b, which is a potent growth inhibitor for hepatocytes. This observation implies the resistance to growth inhibitory effects caused by the autocrine TGF-b signal in human HCC (de Caestecker et al., 2000) . However, it remains unclear whether the endogenous TGF-b signal and transcriptional regulations of PAI-1 and VEGF genes are linked during hepatocarcinogenesis.
Progress over the past several years had elucidated how TGF-b initiates its response. Members of the TGFb family exert their function by binding to and activating specific pairs of receptor serine/threonine kinases. The TGF-b family members interact with the type II receptor, which, in turn, recruits the type I receptor (TbRI) into a heteromeric receptor complex, and then the ligand-binding type II receptor kinase is constitutively active and activates TbRI by phosphorylation of serine and threonine residues in the GS box (Massague´, 1998) . The activated TbRI phosphorylates the serine residues within the conserved SSXS motif at the C-terminus of receptor-regulated Smads (R-Smads), such as Smad2 and Smad3 (Macı´as-Silva et al., 1996) . These phosphorylated R-Smads heteromerize with a common partner Smad4, and then accumulate in the nucleus. The activated Smad complex binds to target promoters including PAI-1 and VEGF in association with DNA-binding cofactors, and recruits coactivators to activate transcription (Derynck et al., 1998) . Alternatively, the activated Smad complex can also recruit corepressors, which in turn bind histone deacetylases. As a result, Smads can either positively or negatively regulate the transcription of specific genes in response to TGF-b signaling (Wrana, 2000) . In addition to these positively acting Smads, Smad7 blocks the phosphorylation of R-Smads by acting as a pseudosubstrate for TbRI. Interestingly, transcription of Smad7 gene is induced by TGF-b, providing a negative feedback mechanism for the regulation of Smad signaling (Nakao et al., 1997) .
We previously demonstrated that R-Smads activated by autocrine TGF-b signal propagate the negative or positive growth signal in cultured HCC cells, and that they play an important function in the regulation of gene-specific transcriptional responses (Matsuzaki et al., 2000a, b) . The activated R-Smads might determine the biological character of human HCC, such as invasive activity and metastatic behavior. On the other hand, mutations have been reported in the signaling molecules, including in Smad2 and Smad4, of some HCC cells (Yakicier et al., 1999) . Accordingly, it is important to investigate whether the inactivation of the signaling molecules modulates the character of human HCC by blocking autocrine TGF-b signal pathway. In the present study, we found that the inhibition of Smad2 activation did not shut off the entire TGF-b signaling pathway, but altered the pathway to allow for the preferential usage of Smad3, leading to upregulation of factors that are involved in metastasis and angiogenesis. Thus, such an alteration of Smad signaling would enhance the malignant potential in addition to increasing resistance to the antiproliferative effects of TGF-b.
Results

Establishment of Smad transfectants from HuH-7 cells
Considerable experimental evidence supports a model of TGF-b signaling that involves the phosphorylation of serine residues within the conserved SSXS motif at the C-terminus of R-Smads by the kinase present in TbRI (Macı´as-Silva et al., 1996) . Accordingly, Smad2(3S-A) and Smad3(3S-A), in which the serine residues of SSXS motif are changed to alanine, can act as dominantnegative mutants by blocking the functions of endogenous R-Smad proteins. To investigate the effects of the TGF-b signal on the biological features of human HCC, we selected HuH-7 cells, which are known to be a welldifferentiated HCC line and sensitive to the TGF-b signal (Fan et al., 1996) .
We generated four types of HuH-7 clones, which had been stably transfected with expression vectors encoding Flag-tagged Smad proteins. Two representative clones were selected from cells transfected with wild-type RSmads (2WT-ST1B3, 3WT-ST1B3). Two others were selected that had been transfected with dominantnegative Smad2 (2SA-ST1B3) or Smad3 (3SA-ST1 B2). Initially, we investigated the expression levels of exogenous Smad proteins in each stable transfectant. After the cells were metabolically labeled with [ 35 S]methionine, the cell lysates were precipitated with anti-Flag antibody (Ab) and visualized by autoradiography (data not shown). We chose the clone showing the highest expression of Smad proteins, and performed further molecular analyses. We next confirmed whether the expressions of exogenous Smads overwhelmed those of endogenous Smads. For this purpose, we compared the mRNA levels of exogenous Smads with those of endogenous Smads by Northern blot hybridization ( Figure 1a) . mRNAs of 3.4 and 2.9 kb would correspond to endogenous Smad2, and 2.4 kb mRNA would correspond to exogenous Smad2 (lanes 2 and 3). The mRNA of exogenous Smad2(3S-A) in 2SA-ST1 cells was more abundant than that of endogenous Smad2 (lane 3), whereas 2WT-ST1 cells showed relatively low levels of exogenous wild-type Smad2 expression (lane 2). mRNAs of 4.9 and 2.5 kb would correspond to endogenous Smad3, and 2.0 kb mRNA would correspond to exogenous Smad3 (lanes 4 and 5). Expressions of exogenous wild-type Smad3 in 3WT-ST1 cells and Smad3(3S-A) in 3SA-ST1 cells were significantly higher than that of endogenous Smad3. The intensities of mRNA for Smads were normalized to the signals of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Since all the Smad constructs were Flag-tagged, we could monitor protein expression levels of Flag-Smads among the transfectants. Followed by immunoprecipitation of cell lysates of parental HuH-7 cells and stable transfectants with anti-Flag Ab, Flag-Smads proteins were detected by immunoblot using anti-Flag Ab (Figure 1b, upper panel) . The results showed that Flag-Smad2WT, Smad2(3S-A), Smad3WT, and Smad3(3S-A) proteins were expressed in the transfectants. We next compared the protein levels of exogenous gene products with those of endogenous R-Smads in the stable transfectants. The ratio of exogenous R-Smads to endogenous R-Smads, in the samples immunoprecipitated with anti-Smad2/3 Ab, was determined by immunoblot using anti-Smad2/3 Ab (Figure 1b , lower panel). Sufficient differences in size between exogenous R-Smads and endogeous ones allowed us to know the expression levels of these R-Smads. Thus, Flag-tagged R-Smads migrated slightly slower than endogenous RSmads. The results showed that Flag-Smad2(3S-A) in 2SA-ST1 cells was more abundant than that of endogenous Smad2 (lane 3), whereas 2WT-ST1 cells showed relatively low levels of Flag-Smad2 expression (lane 2). Expression of Flag-Smad3WT in 3WT-ST1 cells or Flag-Smad3(3S-A) in 3SA-ST1 cells was significantly higher than that of endogenous Smad3. These results were similar to the expression profiles at the mRNA levels among the transfectants. Collectively, the present findings suggest that the expression of exogenous R-Smads(3S-A) was sufficiently high to overwhelm that of endogenous Smads, and that RSmads(3S-A) proteins could selectively block their specific signal through the phosphorylated Smads in these transfectants.
By Northern blot hybridization and ELISA techniques, we further examined TGF-b 1 expression and secretion into the culture media in parental HuH-7 cells and stable transfectants. Surprisingly, both 2SA-ST1 and 3SA-ST1 cells displayed significant autoinduction of TGF-b 1 at both the protein and mRNA levels ( Figure  2a, b) . To examine the role of TGF-b signaling in liver carcinogenesis, we investigated the mRNA expression of type I and type II TGF-b receptors in these cells. Both parental HuH-7 cells and stable transfectants expressed the type I and type II receptor mRNAs (data not shown). Since TGF-b 1 expression was elevated in all stable transfectants, and the cells expressed TGF-b receptors and Smads, it is possible that TGF-b 1 propagates its autocrine signal in these cells.
Autocrine TGF-b signal propagates through the activated Smad3 in 2SA-ST1 cells Mutations in Smad2 gene have been reported in various types of human cancer, and are an important factor in tumor progression (Riggins et al., 1997 Next, the protein levels of exogenous gene products were compared with those of endogenous R-Smads in the stable transfectants (lower panel). The ratio of exogenous R-Smads to endogenous RSmads in the anti-Smad2/3 (aSmad2/3) immunoprecipitated samples was determined by IB using anti-Smad2/3 Ab. Flag-tagged R-Smads migrate slightly slower than endogenous R-Smads Figure 3B , exogenous TGF-b 1 enhanced the phosphorylation of Smad3. However, neither the phosphorylation of Smad3(3S-A) nor that of Smad2(3S-A) was not induced by TGF-b 1 treatment. In addition, the basal level for Smad3WT phosphorylation was reduced by the addition of neutralizing Ab against TGF-b (lane 3 compared with lane 1). These results indicate that ligand-dependent Smad3 phosphorylation occurs by an autocrine mechanism. We further attempted to confirm whether or not endogenous Smad3 was phosphorylated by TGF-b in the cells. For this purpose, we determined the phosphorylated state of Smad3 by immunoprecipitation of the metabolically labeled cell lysates with anti-Smad3 Ab. Liganddependent phosphorylation of endogenous Smad3 was also observed in 2SA-ST1 cells ( Figure 3C ). Collectively, Smad2(3S-A) expression did not inhibit the phosphorylation of Smad3 in response to TGF-b signal.
We further confirmed that ligand-dependent signaling occurred at the downstream steps in the TGF-b-induced activation of R-Smads. Key events in this process include the translocation of R-Smads into the nucleus. To determine whether TGF-b could influence nuclear translocation of R-Smads, we observed subcellular localization by indirect immunofluorescence microscopy after TGF-b 1 treatment. In parental HuH-7 cells used as a control, R-Smads proteins were localized in the cytoplasm in unstimulated culture and the TGF-b signal did translocate R-Smads into the nucleus ( Figure 3D , a-d). However, even in the presence of the TGF-b signal, Smad2 protein was predominantly located in the cytoplasm of 2SA-ST1 cells ( Figure 3D , E and F), indicating that the mutant Smad2 functioned in a dominant-negative fashion. By contrast, most 2SA-ST1 cells showed a ligand-dependent accumulation of Smad3 into the nuclei ( Figure 3D , G and H). These results indicate that the TGF-b signal can translocate Smad3 protein into the nucleus in a Smad2-independent manner. Similar to the phosphorylation results, Smad3(3S-A) overexpression blocked nuclear translocation of both Smad2 and Smad3 in 3SA-ST1 cells ( Figure 3D , i-l).
The heteromeric complex formation of R-Smads with Smad4 in response to TGF-b is also critical for TGF-b/ Smad signaling. Accordingly, we investigated whether TGF-b signal had an effect on the complex formation between R-Smads and Smad4 in parental HuH-7, 2SA-ST1, and 3SA-ST1 cells. After the cells were treated with TGF-b 1 , cell lysates were subjected to immunoprecipitation with anti-Smad4 Ab, and each of the immunoprecipitates was analysed by immunoblot using antiphosphorylated Smad2 Ab. As shown in Figure 3E , an increase in the associations between the phosphorylated Smad2 and Smad4 was observed in parental HuH-7 cells treated with TGF-b 1 . However, TGF-b 1 treatment did not sufficiently induce the complex formation of the phosphorylated Smad2 with Smad4 in both 2SA-ST1 and 3SA-ST1 cells. Next, to investigate heteromeric complex formation of Smad3 with Smad4, 2SA-ST1 cells were transfected with Flag-Smad3 and Smad4-HA in the absence or presence of TGF-b 1 . Cell lysates were Cell lysates were subjected to IP with anti-Smad3 Ab (aSmad3) and visualized as described above. To determine total protein levels, cell lysates were subjected to IB analyses with anti-Smad3 Ab (lower panel). pSmad3; phosphorylated Smad3. (D) In contrast with the blockage of TGF-b-dependent nuclear translocation of Smad2, the TGF-b signal translocates Smad3 protein into the nuclei in stable Smad2(3S-A) transfectants. Parental HuH-7, 2SA-ST1, or 3SA-ST1 cells were incubated in the absence or presence of 200 pm TGF-b 1 for 1 h. Smad2 or Smad3 was detected by immunofluorescence using antibody against Smad2 (aSmad2) or Smad3 (aSmad3) followed by FITC-conjugated secondary Ab, and analysed by confocal microscopy. (E) TGF-b treatment does not sufficiently induce the complex formation of the phosphorylated Smad2 with Smad4 in stable R-Smads(3S-A) transfectants. Parental HuH-7, 2SA-ST1, or 3SA-ST1 cells were incubated in the absence or presence of 200 pm TGF-b 1 for 1 h. Cell lysates were subjected to anti-Smad4 (aSmad4) IP and then were IB with anti-phosphorylated Smad2 Ab (apSmad2) (upper panel). The expression of Smad2/3 or Smad4 was monitored by IB using anti-Smad2/3 Ab (aSmad2/3) (middle panel) or anti-Smad4 Ab (lower panel). (F) TGF-b-dependent heteromeric complex of Smad3 with Smad4 in stable Smad2(3S-A) transfectants. 2SA-ST1 cells were transiently transfected with the indicated combinations of Flag-Smad3 and Smad4-HA, followed by incubation in the absence or presence of 200 pm TGF-b 1 . Cell lysates were subjected to anti-Flag (aFlag) IP and then were IB with anti-HA Ab (aHA) (upper panel). The expression of transfected DNAs was determined by IB of total cell lysates using anti-Flag Ab or anti-HA Ab. (G) Endogenous Smad3 activated by TGF-b associates with endogenous Smad4 in stable Smad2(3S-A) transfectants. 2SA-ST1 cells were incubated in the absence or presence of 200 pm TGF-b 1 . Cell lysates were subjected to anti-Smad3 (aSmad3) IP and then were IB with anti-Smad4 Ab (aSmad4) (upper panel). The relative levels of endogenous Smad3 and Smad4 were monitored by direct IB of total cell lysates subjected to immunoprecipitation with anti-Flag Ab and the immunoprecipitates were analysed by immunoblot using anti-HA Ab. As shown in Figure 3F , an increase in the association between Smad3 and Smad4 was observed in the cells treated with TGF-b 1 . Liganddependent association of endogenous Smad3 with endogenous Smad4 was also confirmed ( Figure 3G ). The results indicate that TGF-b signaling induces the formation of heteromeric complex composed of Smad3 and Smad4 in 2SA-ST1 cells. Thus, the results obtained in this study are because of specific perturbation of the Smad2 signals by Smad2(3S-A) overexpression.
Smad2 inactivation leads to upregulations of PAI-1 and VEGF by the activated Smad3
PAI-1 is involved in tumor growth, metastasis, and angiogenesis (Gutierrez et al., 2000) . Clinically, serum TGF-β β (Shirai et al., 1994; Zhou et al., 2000) .
To examine the response of the autocrine TGF-b signal to PAI-1 transcription in these transfectants, we investigated PAI-1 expression and secretion into the culture media by Northern blot hybridization and ELISA. The PAI-1 expression was significantly increased at both the protein and mRNA levels in 3WT-ST1 and 2SA-ST1 cells (Figure 4a, b) . To obtain the evidence that R-Smads phosphorylation by endogenous TGF-b is involved in TGF-b signaling, we investigated the effects of TGF-b on PAI-1 promoter activity. For these assays, we used PF1-Luc, which contains a promoter segment from -794 to -532 in the PAI-1 gene sufficient for the TGF-b-dependent induction (Hua et al., 1998) . The cells transfected with PF1-Luc were incubated overnight in the absence or presence of TGFb 1 , and the relative luciferase activity was measured in (Figure 4c ). This activation was more potentiated in the cells expressing wild-type Smad3 than in those expressing wild-type Smad2, and was lost in the cells expressing Smad3(3S-A), suggesting that TGF-b signaling is mainly propagated through Smad3. As expected, transfection of PF1-Luc alone into 2SA-ST1 cells resulted in the elevated basal levels of transcription in unstimulated cells, and this transcription was significantly induced by stimulation with exogenous TGF-b 1 . These results suggest that autocrine TGF-b pathway is involved in the transcriptional activation of the PAI-1 gene. To prove more direct involvement of the increased Smad3 and Smad4 in PF1 promoter activity, we cotransfected each TGF-b signal component with PF1-Luc. Cotransfection with wild-type Smad3 or Smad4 increased the sensitivity of the cells (Figure 4d ). In contrast, cotransfection with Smad3(3S-A) or C-terminal truncated Smad4 (Smad4DC) led to suppression of the PF1 promoter activity. These results demonstrate direct evidence that autocrine TGF-b signals, despite the Smad2 signal blockage, are propagated through Smad3-Smad4 complex in 2SA-ST1 cells.
Since VEGF contributes to tumor angiogenesis in HCC (Mise et al., 1996; Ferrara, 1999) , we next focused our analysis on the VEGF gene as a target of the autocrine TGF-b pathway. Similar to the profile of PAI-1 expression among the transfectants, VEGF expression increased in 3WT-ST1 and 2SA-ST1 cells (Figure 5a) . A large amount of VEGF secretion into the culture media was also observed in these cells (Figure 5b ). We further studied the exogenous TGF-b 1 effects on VEGF 3 H]thymidine incorporation was achieved by TGF-b 1 treatment in the cells carrying wild-type Smad2. This suppression was more potentiated in 3WT-ST1 cells than in 2WT-ST1 cells, and such suppression was lost in 3SA-ST1 cells, suggesting that the activation of Smad3 is essential for the growth inhibitory signaling in HuH-7 cells. Similar resistance to its growth inhibitory effects was observed in 2SA-ST1 cells. Taken together the findings that autocrine TGF-b signals were mainly propagated through the activated Smad3-Smad4 complex in 2SA-ST1 cells, the data indicate that an achievement of this negative cell growth effect requires Smad2 phosphorylation in HuH-7 cells.
Highly expressed in HCC tissues, a-fetoprotein (AFP) is widely used for the diagnosis of HCC and monitoring of HCC patients, and increased AFP production in human HCC patients reflects the DNA synthesis of tumor cells (Abelev, 1971) . Therefore, we finally wanted to confirm whether autocrine TGF-b signal affects AFP production of HCC. Among all of the transfectants, 2SA-ST1 cells produced the largest amount of AFP (Figure 7) , indicating that the TGF-b signal is involved in the regulation of AFP production in HCC.
Discussion
Variations in TGF-b-mediated Smad activation and heteromeric complex formation were recently reported in studies of TGF-b signal transduction (Piek and Roberts, 2001) . It is true that the 3S-A derivatives of Smad2 and Smad3 act as dominant-negative mutants by Massague´, 1998) . The specificity of TGF-b signaling is, in part, determined by the combination of different Smad complexes (Zhang and Derynck, 1999) . Accordingly, the ratio of the activated Smad2 to Smad3 can affect the transcriptional regulations of the proximal target genes. PAI-1 expression is tightly regulated by hormones and cytokines including TGF-b (Healy and Gelehrter, 1994) . Besides acting as the main inhibitor of the urokinase-type plasminogen activator system, PAI-1 has been shown to be an important regulator of extracellular matrix interactions (Gutierrez et al., 2000) . In particular, observations that neoplastic cells including HCCs express elevated levels of PAI-1 suggest that this protein is involved in tumor migration, invasion, and metastasis by blocking cellular adhesion and by promoting the degradation of basement membrane (Dan et al., 1985; Bajou et al., 1998; Zhou et al., 2000) . Confirming the importance of fibrinolytic components and the cancer phenotype, clinical studies have demonstrated that a high PAI-1 level is associated with a poorer prognostic outcome (Pedersen et al., 1994a, b) . It is also well known that the development of tumor cells requires oxygen and nutrients, which are supplied through neovascularization. Angiogenic potential is, therefore, a prerequisite for tumor growth. Several factors participating in the development of microvasculature have been identified. Among them, VEGF is the most intriguing factor in (Dvorak et al., 1991) . A correlation exists between the degree of vascularization of the malignancy and VEGF expression in human HCC. Also, elevations in VEGF levels have been detected in the serum of HCC patients (Mise et al., 1996) . Immunohistochemical studies have localized the VEGF protein not only to the tumor cells, but also to the vasculature associated with such tumors (Mise et al., 1996) . This localization indicates that tumor-secreted VEGF accumulates in the target cells, confirming that VEGF is a potent neovascularization agent in human HCC. Our current results demonstrated that treatment of HuH-7 cells with TGF-b resulted in inductions of PAI-1 and VEGF mRNAs and release of these proteins in the culture media, thus providing a possible network among the TGF-b signal, extracellular protease activity, and angiogenesis. Interestingly, both PAI-1 and VEGF were significantly induced in Smad2(3S-A) transfectants. Importantly, forced expression of Smad3(3S-A) blocked TGF-b-induced transcriptional activation, and such transcriptional activation could be stimulated by overexpression of wild-type Smad3. These results prove direct evidence that the autocrine TGF-b signal enhances PAI-1 and VEGF production through Smad3-Smad4 complex. In addition, TGF-b-dependent Smad3 activation caused by blockage of Smad2-mediated signal, enhances PAI-1 and VEGF production, and leads to the development of HCC (Figure 8 ).
Our findings also shed light on the mechanism why HCC is resistant to the growth inhibition induced by the TGF-b signal. Obtaining the resistance to TGF-b in cancer cells has been thought to be one of the important factors in malignant transformation, since TGF-b is a potent natural antiproliferative cytokine for normal epithelial cells. Tumor cells often escape the antiproliferative effects of TGF-b by mutational inactivation or dysregulated expression of components such as TGF-b receptors and/or Smad proteins in its signaling pathway (de Caestecker et al., 2000; Miyazono et al., 2001) . Our findings demonstrated that stable transfectants of either Smad2(3S-A) or Smad3(3S-A) acquired resistance to this antiproliferative effect, and implied that the antiproliferative signal was mediated through the heterotrimer comprised of Smad2, Smad3, and Smad4 in HuH-7 cells. These results are consistent with a report that the TGF-b-induced growth inhibitory signal was mediated by the heterotrimeric complex of Smad2, Smad3, and Smad4 (Feng et al., 2000) . Accordingly, the functional deficiency of Smad2 or Smad3 would cause the cells to resist growth inhibition by TGF-b.
TGF-b 1 mediates its autoinduction by Smad signaling. In our studies, an autoinduction of TGF-b 1 was displayed in both Smad2(3S-A) and Smad3(3S-A) transfectants. This interesting phenomenon suggests the possibility that TGF-b-mediated autoinduction does not necessarily require the heterotrimer comprised of Smad2, Smad3, and Smad4. Since Smad2, in contrast to Smad3, cannot bind to DNA directly, Smad2 and Smad3 may have a different subset of target genes and thus regulate distinct gene responses (Massague´, 1998) . Therefore, a different balance of the TGF-b signal through the Smad2 and Smad3 pathway may affect TGF-b 1 transcription. Otherwise, the transcriptional regulation of the TGF-b gene can be reflected by mitogen-activated protein kinase pathways through the activator protein-1 complex (Kim et al., 1990) .
To date, the TGF-b pathway has been found to be inactivated in human tumor cells through a variety of mechanisms, including mutational inactivation of Smad2 and Smad4 proteins (Riggins et al., 1997) . Moreover, numerous reports have explained the mechanisms relating mutational inactivation of Smads to malignant transformation (Miyaki et al., 1999; Schwarte-Waldhoff et al., 2000; Prunier et al., 2001) . On the other hand, resistance to growth inhibition by TGF-b does not necessarily mean a complete loss of TGF-b signaling, but rather suggests that tumor cells acquire an advantage by selective loss of the tumor suppressor activities of TGF-b while retaining its tumor-promoting activities including tumor invasion, metastasis, and angiogenesis (Engel et al., 1998) . These phenomena might occur not only in our stable transfectant models but also in Smad knockout/ transgenic animals and in spontaneous human cancer cells bearing mutational inactivation in Smads. Based on our data, the signaling pathway from other Smad components, except for the mutationally inactivated Smad, can remain intact in these animal models or human cancer tissues. Further studies will be required to elucidate whether the altered TGF-b signal caused by Smad mutational inactivation leads to modification of biological features in such cases.
Nucleus
Materials and methods
Cell culture procedure
HuH-7 cells and stable transfectants were grown as subconfluent monolayer cultures in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal calf serum (FCS). All experiments, except the measurement of proteins secreted from the cells in the culture media, were carried out in the log phase of growth after the cells had been plated for 24 h.
Northern blot hybridization analysis mRNAs were isolated and hybridized with labeled cDNA probes for TGF-b 1 , Smad2, Smad3, PAI-1, and human GAPDH as described (Date et al., 1998) . To determine human VEGF mRNA levels, 0.52-kb PCR (forward, 5 0 -GACG-CCCTCCGAAACCATGAAC-3 0 ; reverse, 5 0 -CAGCCTG-GCTCACCGCCTTG-3 0 ) fragment of mouse VEGF was used as the cDNA probe.
Measurement of TGF-b 1 , PAI-1, VEGF, and AFP by ELISA For measurement of the concentrations, the cells were plated in flasks and incubated for 24 h in regular growth medium. After having reached 60-80% confluency, the monolayers were washed twice and replaced by serum-free DMEM. The culture media were collected 60 h later. To determine the concentrations of TGF-b 1 , VEGF, PAI-1, and AFP in the media, we used the enzyme-linked immunoassay kits for human TGF-b 1 (R&D System, Minneapolis, MN, USA), VEGF (R&D System), PAI-1 (Biopool, Umea˚, Sweden), and AFP (DAINABOT, Tokyo, Japan). 4 cells were plated in six-well plates, and incubated for 24 h in regular growth medium. The cells were changed to serum-free medium in the absence or presence of 40 pm recombinant human TGFb 1 (R&D System), and incubated for 20 h. DNA synthesis was measured by the incorporation of 1 mCi/ml [ 3 H]thymidine (Amersham Pharmacia Biotech, Buckinghamshire, UK) into 5% trichloroacetic acid-precipitable material after a 4 h pulse, as previously described (Matsuzaki et al., 1990) . Experimental and control values were compared using the unpaired Student's t-test and ANOVA; Po0.05 was considered to be significant.
Constructs and reagents
Mammalian expression vectors with an N-or C-terminal tag (Flag or HA) were constructed by inserting oligonucleotides encoding for epitope-tag sequences into pcDNA3 (Invitrogen, San Diego, CA, USA). The coding regions of Smad2, Smad3, and Smad4 were amplified by PCR and subcloned into Flagor HA-pcDNA3. Mutants of Smad2(3S-A) and Smad3(3S-A) were produced by PCR-based mutagenesis as previously described (Matsuzaki et al., 2000a) . The cDNA for dominant-negative Smad4DC (truncation of the C-terminal 39 amino acids) was amplified by PCR (forward, 5 0 -GGGAATTCGGACAATATGTCTATTACGA-3 0 ; reverse, 5 0 -GCGTCGACTGGGTAATCCGGTCCCCAGC-3 0 ) and subcloned into Flag-tagged pcDNA3. The PF1 element, which comprises base pairs from -794 to -532 of human PAI-1 promoter, was amplified by PCR (forward, 5 0 -TATCTCGAG-TACCATGGTAACCCCTGG-3 0 ; reverse, 5 0 -GGAAGCT-TAACAGCCACAGGCATGCA-3 0 ) and subcloned into pGL3-Basic (Promega, Madison, WI, USA). The integrity of the constructs was confirmed by sequencing.
Transient transfection, immunoprecipitation, and immunoblot
The conditions for cell culture and transfection have been described elsewhere (Matsuzaki et al., 2000a) . The cells were analysed at 48 h after transfection with the indicated combinations of constructs by LipofectAMINE (GIBCO/BRL, Rockville, MD, USA). The cells were incubated in the absence or presence of 200 pm TGF-b 1 for 1 h. Alternatively, the cells were incubated with 5 mg/ml anti-TGF-b neutralizing Ab (R&D System) for 24 h. Subsequently, they were dissolved in the lysis buffer (10 mm Tris-HCl (pH 7.5), 150 mm NaCl, 1% NP40, 1 mm EDTA, 10 mg/ml aprotinin, and 0.3 mm phenylmethylsulfonyl fluoride). To monitor the protein levels of endogenous Smads and exogenous gene products, lysates were subjected to immunoprecipitation with anti-Smad2/3 Ab (Transduction Laboratories, Lexington, KY, USA) followed by absorption to protein G Sepharose (Pharmacia Biotech, Wikstro¨ms, Sweden). For the heteromeric complex experiments, lysates were immunoprecipitated with anti-Smad4 Ab (Abcam, Cambridge, UK), anti-Flag M2 Ab (Kodak, New Haven, CT, USA), or antiSmad3 (I-20) Ab (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The bound protein was eluted by heating in SDS-PAGE sample buffer containing DTT. Samples were subjected to SDS-PAGE and then were transferred to nitrocellulose membranes (Hybond-ECL RPN303D; Amersham). Immunoblot was performed using the following primary antibodies: anti-phosphoSmad2 (Ser 465/467) Ab (Upstate Biotechnology, Lake Placid, NY, USA); anti-Smad2/3 Ab; anti-Smad3 (I-20) Ab; antiSmad4 (B-8) Ab (Santa Cruz Biotechnology); anti-Flag M2 Ab; anti-HA Ab (BAbCO, Richmond, CA, USA). The blots were incubated with primary Ab for 1 h at room temperature and then were washed three times. The appropriate secondary Ab was added for 1 h at room temperature. After washing, the immunoreactive proteins were visualized by ECL (RPN2106; Amersham) and autoradiography.
Metabolic labeling
Conditions for transfection and metabolic labeling have been described (Matsuzaki et al., 2000a) . Briefly, the cells were incubated for 12 h in serum-free DMEM in the absence or presence of 5 mg/ml anti-TGF-b Ab. The cells were preincubated with phosphate-free DMEM (GIBCO/BRL) for 3 h, incubated with the same phosphate-free media containing 300 mCi/ml [ 32 P]phosphate (Amersham) for 2 h at 371C, and then stimulated with 200 pm TGF-b 1 for 45 min. Subsequently, metabolic-labeled cells were solubilized in the lysis buffer at 41C. The lysates were precipitated with anti-Flag M2 Ab, resolved by SDS-PAGE, and visualized by autoradiography. To determine the total protein levels, the samples after radioactive decay were subjected to immunoblot with antiFlag M2 Ab and chemiluminescence (ECL; Amersham) as described above. In the experiments for the phosphorylation of endogenous Smad3, the cell lysates were precipitated with antiSmad3 (I-20) Ab. For determination of the total protein levels, aliquots of their lysates before immunoprecipitation were used for immunoblot with anti-Smad3 (I-20) Ab after radioactive decay.
Stable transfection of Smads
The conditions for cell culture and transfection have been described (Matsuzaki et al., 2000b) . For stable transfectants, HuH-7 cells were transfected with the indicated constructs by LipofectAMINE. Selection was initiated with 800 mg/ml of G418 (Life Technologies, Rockville, MD, USA) and continued for several weeks until drug-resistant colonies emerged.
Immunofluorescence study Subcellular localization of Smad2 was determined as previously described (Matsuzaki et al., 2000a) . The cells were seeded onto slides and incubated for 24 h. The cells were then incubated in the absence or presence of 200 pm TGF-b 1 for 1 h. After fixation with 4% paraformaldehyde, slides were incubated with anti-Smad2 Ab or anti-Smad3 (I-20) Ab at 41C for 16 h. Then, Alexa Fluort labeled goat anti-mouse IgG or rabbit anti-goat IgG (COSMO BIO, Tokyo, Japan) was added. After mounting the slides with Perma Fluort Aqueous Mounting Medium (Shandon Lipshaw, Pittsburgh, PA, USA), the cells were observed by a fluorescence microscope.
Transcriptional response assay
The cells were seeded at 1 Â 10 5 cells per well into six-well clusters, and then were incubated for 24 h in regular growth medium. They were subjected to transfection with LipofectA-MINE, 0.4 mg of reporter plasmid, and the indicated constructs or with an empty vector alone, and incubated for 4 h. After wash with the medium, the cells were cultured for 24 h in 0.5% FCS/DMEM, and then were further incubated for 24 h in the absence or presence of 200 pm TGF-b 1 . The cells were lysed, and the luciferase activity of the cell extracts was measured by a luminometer (Berthold, Bad Wildbad, Germany) using Dual-Luciferase TM Reporter Assay System (Promega). The luciferase activities were normalized based on the Renilla luciferase activity.
